Exploring the Potential of UHPLC‐Q‐Orbitrap HRMS‐Based Untargeted Metabolomics for Discriminating Spatholobus suberectus Dunn From Its Adulterants

Documenti analoghi

• Exploring the Material Basis of Taxillus chinensis in the Treatment of Hyperuricemia Nephropathy Through Absorbed Into Blood Component Analysis and Network Pharmacology
  di: Jiemei Liang, et al.
  Pubblicazione: (2025)
• Comprehensive Analysis of Bioactive Phytoconstituents in Red Flesh of Dioscorea opposita Thunb. by UHPLC‐Q‐Orbitrap‐HRMS
  di: Lanping Yang, et al.
  Pubblicazione: (2025)
• Elucidating the Therapeutic Mechanisms of Dendrobium loddigesii in Gastric Mucosal Injury: An Integrated Approach Combining Serum Metabolomics and Network Pharmacology
  di: Qiyuan Yang, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and Metabolism of ARV‐393, a BCL6 PROTAC Degrader, in Dogs by UPLC–MS/MS and UPLC‐Q‐Exactive Orbitrap‐HRMS
  di: Qiuyan Wang, et al.
  Pubblicazione: (2026)
• Untargeted Metabolomic Study on the Mechanism of Polygonatum sibiricum in Non‐Alcoholic Fatty Liver Disease in Rats Using UPLC‐Q‐TOF/MS
  di: Xintong Li, et al.
  Pubblicazione: (2025)